2000

Jun 13, 2000
Guidant Supports Capitol Hill Briefing on Women''s Health and Cardiovascular Disease

Briefing Serves as a Call to Action to Address Significant Health Concern Indianapolis, IN - In an effort to provide increased visibility to a growing public health crisis-cardiovascular disease...

Nov 15, 2000
Intravascular Beta Radiation Therapy Shown to Reduce Recurrence of Coronary Artery Blockages

Data from INHIBIT Trial Shows In-Stent Restenosis Reduction With Radiotherapy Indianapolis, Ind. and Santa Clara, Calif. - Results from the INHIBIT (INtimal Hyperplasia Inhibition with Beta...

Dec 21, 2000
Guidant and the University of Medicine and Dentistry of New Jersey Launch Clinical Trial to Study Carotid Artery Stenting and Carotid Endarterectom

Landmark Study Examines Minimally Invasive Alternative for Treating Carotid Artery Disease Indianapolis, Ind., Santa Clara, Calif. and Newark, N.J. - Guidant Corporation (NYSE and PCX: GDT) and...

Dec 19, 2000
Guidant Files for FDA Approval of its GALILEO Intravascular Radiotherapy System

Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease, announced today that is has filed with the U.S....

Dec 14, 2000
Guidant Participates in Unprecedented Partnership to Rapidly Bring Cardiovascular Technology to Market

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in the development of medical technology for the treatment of cardiovascular and vascular disease, today announced...

Show 5102550100 per page
Top